| ADME | Absorption, Distribution, Metabolism, Excretion |
| ALN | Alendronate |
| BDC | Benzene Dicarboxylic Acid |
| BTC | Trimesic Acid |
| CMC | Carboxymethylcellulose |
| DAMPs | Damage-Associated Molecular Patterns |
| DDS | Drug Delivery System |
| DOX | Doxorubicin |
| DV | Doxorubicin–Vitamin E Succinate |
| DZ | Monolayer DOX encapsulated ZIF-8 |
| DZZ | DOX-loaded ZIF-8 coated with ZIF-8 |
| FC | Folic acid-conjugated chitosan |
| FU | Fluorouracil |
| GSDMD | Gasdermin D |
| GSH | Glutathione |
| HF | Hydrofluoric Acid |
| ICD | Immunogenic Cell Death |
| LCST | Lower Critical Solution Temperature |
| LMP | Lysosomal Membrane Permeabilization |
| MDR | Multidrug Resistance |
| MR | Magnetic Resonance |
| MIL | Materials of Institut Lavoisier |
| NMOF | Nanoscale Metal–Organic Framework |
| NIR | Near-Infrared |
| PDT | Photodynamic Therapy |
| PEG | Polyethylene Glycol |
| PNIPAM | Poly(N-isopropylacrylamide) |
| PNVCL | Poly(N-vinylcaprolactam) |
| PTT | Photothermal Therapy |
| ROS | Reactive Oxygen Species |
| UCNP | Upconversion Nanoparticles |
| TME | Tumor Microenvironment |
| XRD | X-ray Diffraction |
| 5-FU | 5-Fluorouracil |
| 3-MA | 3-Methyladenine |